Arch Therapeutics Inc (ARTH)

[volatility magnet]

Just an FYI to all those who keep postulating a buy out: as a business owner of 3 companies in the medical field, I will have to say, it is my opinion, that Norchi and the directors , would be fools to sell the company after a small success of 1 application of the more than 200 potential applications, come to fruition. It is public knowledge that arch has no intention of manufacturing, building a sales force and "going it alone". However, the logical business move is to license each product and/or partner with established medical companies, for each product application that comes to fruition. In other words, if the company has multiple applications that have not even been introduced to trials yet, why would the company just give all intellectual property away because 1 minuscule application got approved. Do you think Norchi will give away all the patents and intellectual property away just because a 50 pt trial was successful on external use for superficial skin surgery? Internal application and chronic wound care application is the bank. 50 times more potential value. Ps. I use to speak on behalf of Dermabond ( now a jnj product). I'm a MD. I own a small pharmacy, a medical facility and I'm a biochemist. All of the above are mentioned only to explain my interest in arch. I get it. I understand it's science and I believe in its value. Full disclosure, I have accumulated 596,000 shares gradually since 2013. I have not sold any shares.